Daily Archives: 2012/06/07

Visual Perception Improved With Magnetic Stimulation

2012/06/07
By
Researchers have successfully improved the visual perception of a group of healthy individuals by using a non-invasive technique called transcranial magnetic stimulation (TMS). The study, led by Antoni Valero-Cabré from the Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière (CNRS / Inserm / UPMC), is published in the journal PLoS ONE...

Full Story →

Anti-VEGF Drugs Show Equal Efficacy; Price Vastly Different

2012/06/07
By
A British trial has shown that ranibizumab and bevacizumab are equally effective in the treatment of age-related macular degeneration (AMD).
Medscape Medical News

Full Story →

Tricking Blind Person’s Brain Into Thinking It Is Seeing Things

2012/06/07
By
Researchers have discovered how a visual prosthetic device could stimulate the brain to generate mental images - the blind person could wear eyeglasses with a tiny webcam that transmits data to a computer chip which is implanted in the brain...

Full Story →

CORDA for OCT Image Analysis in Glaucoma Detection

2012/06/07
By
Spectral domain imaging is raising the bar in glaucoma detection.
Medscape Ophthalmology

Full Story →

What is a Fluorescein Angiogram?

2012/06/07
By
A fluorescein angiogram is an invaluable test for a retina specialist. It can help diagnose almost every retinal disease including ARMD and diabetic retinopathy.

Full Story →

CDI introduces MyCell Services

2012/06/07
By
Cellular Dynamics International, Inc. (CDI), the world's largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells, today announced the launch of its MyCell Services.

Full Story →

Hope For More Effective Treatment Of Nearsightedness

2012/06/07
By
Research by an optometrist at the University of Houston (UH) supports the continued investigation of optical treatments that attempt to slow the progression of nearsightedness in children...

Full Story →

DODAC to discuss ThromboGenics’ new BLA for ocriplasmin intravitreal injection

2012/06/07
By
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.

Full Story →

Archives